CIDP and Exercise: What Markvardsen 2018 Proved and How to Program It Around Shift Work

## The question that stops most trainers cold

A client walks in with a neurologist's note that says "stay active." The diagnosis is chronic inflammatory demyelinating polyneuropathy. She works nights as a charge nurse, infuses IVIG every three weeks, and by hour eight of a shift her legs feel like sand. Her physiatrist wants her moving without landing her back in the EMG lab.

For years the default answer was a shrug and a walking program. That answer is no longer defensible. The rehab literature is thin but it is no longer empty, and the central trial tells a specific story that a coach can program against.

Start at the axon

A peripheral nerve is a cable. Axons carry voltage. Schwann cells wrap each axon in lipid-rich myelin that forces action potentials to jump from node to node. That saltatory conduction is why reflexes feel instant and grip feels precise.

CIDP is what happens when the immune system decides the insulation is foreign. Macrophages infiltrate the paranodal region, autoantibodies in some cases target neurofascin-155, contactin-1, or CASPR1, and the axo-glial junction breaks down. Conduction slows. Blocks appear. Strength, sensation, and balance degrade in proportion to how many fibers are involved and how long the process has run.

The useful question is what, physiologically, does exercise do to that exact failure mode.

Five mechanisms, none speculative

1. Neurotrophic support for Schwann cells. Aerobic exercise upregulates BDNF, GDNF, and NGF in peripheral nervous tissue. Schwann cells express receptors for all three. In rodent demyelination models, treadmill training accelerates remyelination and restores internodal length faster than sedentary controls (Bobinski et al., Neuroscience 2018). The wire does not regrow overnight, but the cellular machinery that rebuilds it responds to mechanical and metabolic demand.

2. Motor unit recruitment and collateral sprouting. In a partially denervated muscle, surviving motor neurons sprout collateral axons to reinnervate orphaned fibers. Progressive resistance training is the stimulus. Load forces recruitment of higher-threshold units per Henneman's size principle, and repeated recruitment preserves and expands the functional units that remain. You are not regenerating the failed axon. You are maximally exploiting the ones that still work.

3. Mitochondrial density in partially denervated muscle. Chronically denervated fibers lose oxidative capacity within weeks. Moderate-intensity cycling drives PGC-1alpha, the master regulator of mitochondrial biogenesis, in fibers still under neural control. More mitochondria per fiber means more usable torque per surviving motor unit. This is why VO2peak climbs in CIDP cohorts even when nerve conduction velocity does not.

4. Immune modulation. Acute exercise spikes IL-6 from contracting muscle, which acts systemically as an anti-inflammatory, suppressing TNF-alpha and inducing IL-10 (Pedersen, Physiological Reviews 2020). Chronic training lowers resting CRP and shifts the regulatory T-cell to effector T-cell ratio. In autoimmune demyelinating disease that is background-noise reduction at the level of the process driving the disease.

5. Endoneurial perfusion. Peripheral nerves are perfusion-sensitive. Aerobic conditioning improves endothelial function and capillary density in the vasa nervorum. Better blood flow to the nerve means faster clearance of inflammatory debris and better substrate delivery to the Schwann cells doing repair work.

The question stopped being whether training helps. The remaining question is how much, measured how, and in whom.

What Markvardsen 2018 actually showed

Markvardsen and colleagues at Rigshospitalet (Neurology, 2018) ran two linked 12-week interventions in stable CIDP patients on maintenance IVIG.

Aerobic arm. Supervised cycle ergometer, three sessions per week, progressing toward 70 to 80 percent of VO2peak. VO2peak improved by roughly 11 to 17 percent depending on how it was expressed. Workload at lactate threshold climbed in parallel.

Resistance arm. Progressive isokinetic and isotonic training, three sessions per week, targeting knee extensors, knee flexors, and elbow flexors. Isokinetic knee extensor peak torque rose about 14 percent on the trained side. Fatigue Severity Scale scores dropped meaningfully.

Safety ceiling. Zero participants crossed the pre-specified deterioration threshold on the Overall Neuropathy Limitations Scale, the MRC sum score, or the nerve conduction panel. No training-attributable flares.

This is not a cautious "might help." It is a double-digit effect size in both aerobic and strength domains, in a controlled cohort, with a hard safety readout. A 2021 systematic review in the Journal of the Peripheral Nervous System pooled the broader evidence and landed at the same conclusion: structured aerobic and resistance training are safe and effective in stable CIDP and should be standard adjunct care.

Why "rest" is the wrong default

The traditional caution around exercising demyelinated nerves came from case reports of post-exertional weakness and a conservative read of overwork weakness theory in post-polio syndrome. That extrapolation does not survive contact with CIDP data. In stable disease, detraining is the faster road to decline. A sedentary CIDP patient loses cardiorespiratory capacity on top of the neural deficit, compounding fatigue and falls risk. The neurological disease is immunological. The deconditioning is trainer-addressable. Conflating them is a programming error.

The framework for shift-worker clients with neuropathy

Four constraints define this population: the IVIG cycle, shift rotation, neuropathic fatigue, and autonomic dysregulation. The program moves around all four.

Anchor training blocks to the IVIG cycle, not the calendar week

Maintenance IVIG patients report a predictable arc. Days 1 to 3 post-infusion can include headache and flu-like residue. Days 4 to 14 are the functional peak. The final 3 to 7 days before the next infusion are the wear-off window with returning weakness. Heavy loading sessions belong in the peak window. The wear-off window takes low-intensity zone 2 work and technique practice, not PR attempts. Hughes et al. (Brain, 2008) documented measurable strength fluctuations across the IVIG cycle; this is not superstition.

Match aerobic dosing to Markvardsen, adjusted for shift recovery

The trial used cycle ergometer sessions progressing toward 70 to 80 percent of heart rate reserve, three times per week, 30 to 40 minutes. For a three-twelves night worker that translates to two in-peak-window sessions on post-shift sleep days and one active-recovery ride on a shift day. Cycle ergometer and recumbent options beat treadmill for ataxic patients because the fall-risk math is obvious. Schwann cell proliferation is sleep-dependent; clients consistently under six hours will undertrain on recovery, so aerobic volume drops during sleep-compromised phases rather than intensity rising to compensate.

Resistance train at true progressive load

Neuropathy patients are routinely under-loaded because trainers confuse sensory ataxia with fragility. Markvardsen used 70 to 80 percent of 1RM, three sets, supervised, progressing every two weeks. That is not a gentle protocol. Knee extension, leg press, hip hinge, seated row, chest press, and a loaded carry variant that doubles as autonomic stress. Balance work belongs at the end of the session, not the start, because proprioceptive training under fatigue is where falls get rehearsed. Cap resistance at two sessions per week during night-shift blocks and three per week on day-shift blocks.

Manage autonomics through nutrient density and recovery architecture

Small-fiber autonomic involvement is common in CIDP and presents as orthostatic intolerance, thermoregulation issues, and sleep fragmentation. Night shifts amplify every piece of that. Myelin is lipid, and remyelination needs substrate. Shift workers are chronically under-methylated. Alongside the neurologist's plan we use methylcobalamin 1,000 mcg sublingual (not cyanocobalamin), methylfolate 400 to 800 mcg (not folic acid) to avoid the unmetabolized folic acid problem in MTHFR variants, D3 5,000 IU with K2 MK-7 100 mcg for regulatory T-cell function and bone density under any corticosteroid exposure, magnesium glycinate 400 mg at night for sleep consolidation and cramp reduction, and alpha-lipoic acid 600 mg which carries diabetic neuropathy symptom data (Ziegler et al., Diabetes Care 2006, NNT around 6) with reasonable mechanistic carryover to CIDP sensory symptoms.

Hydration and sodium get programmed, not suggested. A post-infusion day in a dry hospital HVAC environment can pull two to three liters before anyone notices.

Monitor to catch destabilization early

Every four weeks: timed 10-meter walk, 30-second sit-to-stand, grip dynamometry, and a validated fatigue scale. Two consecutive sessions of regression across these markers is a call-the-neurologist signal, not a push-harder signal. This is the line between aggressive rehab and negligence.

The twelve-week frame

Weeks 1 to 2. Baseline: isokinetic testing if available, six-minute walk, grip dynamometry, Fatigue Severity Scale. Submaximal aerobic, bodyweight or banded resistance, technique priority.

Weeks 3 to 6. Aerobic progressed to 65 to 75 percent heart rate reserve, 25 to 35 minutes. Resistance at 60 to 70 percent 1RM, three sets of 8 to 12, targeting knee extension, knee flexion, hip hinge, row, press, and loaded carry.

Weeks 7 to 12. Aerobic to 70 to 80 percent heart rate reserve, intervals introduced if tolerated. Resistance to 70 to 80 percent 1RM, three to four sets, compound lifts prioritized. Re-test at week 12.

Red flags that pause training and return the client to neurology

Subjective weakness outpacing the DOMS window. New sensory level. Bowel or bladder change. Cranial nerve involvement. None of these are training-induced in stable CIDP. The coach's job is to notice them first.

What twelve weeks actually buys

A well-programmed replication of Markvardsen in a stable CIDP client buys a 6-minute walk distance gain in the 50 to 70 meter range, a sit-to-stand jump from the low double digits to the high teens, grip that holds steady in a progressive disease, and a patient who finishes a shift without the mid-shift sit-down. That is the ceiling of what rehab can offer in a demyelinating disease, and it is not nothing. The immunology keeps the disease stable. The training keeps the patient functional. Markvardsen did the hard work of proving it is safe. The rest is programming discipline.

Putting it in practice

At Legacy In Motion we build programs around the client's actual work pattern, IVIG cycle, and methylation and mitochondrial substrate needs. The founder, Jake, is a 40-year-old day-shift hospital security supervisor who lost 112 pounds (308 to 196) in 9.5 months using the same autonomic-first, schedule-aware framework, minus the immunology. The neuropathy population needs that framework more, not less. The infusion schedule is a constraint, not a contraindication, and "stay active" without a protocol is the same as no advice at all.